Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters

Journal of Neuroscience Research

Volumn 68, Issue 5, 2002, Pages 568-578

  Rockenstein, Edward ^a   Mallory, Margaret ^a   Hashimoto, Makoto ^a   Song, David ^a,b   Shults, Clifford W ^a,b   Lang, Ingrid ^c   Masliah, Eliezer ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

synuclein; Lewy body disease, LBD; Multiple system atrophy, MSA; PDGF ; Platelet derived growth factor ( chain); Promoter; Thy 1; Transgenic mice

Indexed keywords

ALPHA SYNUCLEIN; PLATELET DERIVED GROWTH FACTOR; THY 1 ANTIGEN;

ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN STEM; CELL INCLUSION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC SYSTEM; LEWY BODY; MOUSE; NEOCORTEX; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OLFACTORY SYSTEM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA; SYNAPSE; TRANSGENIC MOUSE;

ALPHA-SYNUCLEIN; ANIMALS; ANTIGENS, THY-1; GENE EXPRESSION; HUMANS; LEWY BODY DISEASE; LIMBIC SYSTEM; MICE; MICE, TRANSGENIC; MULTIPLE SYSTEM ATROPHY; NEOCORTEX; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; PLATELET-DERIVED GROWTH FACTOR; PROMOTER REGIONS (GENETICS); SUBSTANTIA NIGRA; SYNUCLEINS;

EID: 0036605566     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10231     Document Type: Article

References (44)

1. 2+-dependent late phase
2. The synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease
3. Diffuse Lewy body disease: Light and electron microscopic immunocytochemistry of senile plaques
4. A Drosophila model of Parkinson's disease
5. Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology
6. Consensus statement on the diagnosis of multiple system atrophy
7. The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity
8. Alpha-synuclein in Lewy body disease and Alzheimer's disease
9. Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease
10. Properties of NACP/alpha-synuclein and its role in Alzheimer's disease
11. The precursor protein of non-Aβ component of Alzheimer's disease amyloid (NACP) is a presynaptic protein of the central nervous system
12. Non-Aβ component of Alzheimer's disease amyloid (NAC) is amyloidogenic
13. Identification of two distinct synucleins from human brain
14. Axonal transport of synucleins is mediated by all rate components
15. Identification of a breast cancer-specific gene, BCSG, by direc differential complementary DNA sequencing
16. Lewy bodies in cerebral cortex. Report of three cases
17. Ala30Pro mutation in the gene encoding α-synuclein in Parkinsons's disease
18. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease
19. The ubiquitin pathway in Parkinson's disease
20. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease
21. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders
22. S100 is preferentially distributed in myelin-forming Schwann cells
23. Cellular localization of PDGF mRNAs in developing human forebrain
24. Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice
25. A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation
26. Aggregation of alpha-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: A survey of six patients
27. Mutation in the α-synuclein gene identified in families with Parkinson's disease
28. Alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes
29. S100 immunoreactivity in a subpopulation of oligodendrocytes and Ranvier's nodes of adult rat brain
30. Levels and alternative splicing of amyloid β protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease
31. Altered expression of the synuclein family in Lewy body and Alzheimer's disease
32. PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model
33. α-synuclein in Lewy bodies
34. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies
35. Synoretin - A new protein belonging to the synuclein family
36. Abnormal distribution of the non-Aβ component of Alzheimer's disease amyloid precursor/α-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment
37. C-terminal α-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders
38. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice
39. Fatal attractions: Abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia
40. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease
41. Neuropathology in mice expressing human alpha-synuclein
42. Cortical Lewy body-containing neurons are pyramidal cells: Laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32
43. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease
44. α-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy